Page 20 - Kd News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The SGLT2 inhibitor empagliflozin (Jardiance) was approved by European regulators for treating adults with chronic kidney disease. The FDA is reviewing a new drug application for this indication. ....
Agents from three novel drug classes showed safety and hints of efficacy in patients with varying stages of chronic kidney disease in three phase 2 studies at the European Renal Association Congress. ....
Malaysian Communications and Multimedia Commission (MCMC) and the Communications and Digital Ministry (KKD) are working in tandem to bolster its cooperation and mutual commitment to the development of Malaysia’s digital economy, according to a statement by MCMC. ....